| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.004 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |